|
End-of-day quote
Korea S.E.
08/10/2026
|
5-day change | 1st Jan Change | ||
| 17,320.00 KRW | -5.04% |
|
-4.04% | -69.83% |
| 07-23 | Samsung EpiS Unit Signs Cancer Drug Development, Commercialization Deal with IntoCell | MT |
| 12-22 | IntoCell, Inc.(KOSDAQ:A287840) added to S&P Global BMI Index | CI |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A287840 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 19,380 | 23,400 | 37,300 |
| Spread/Res. | -10.63% | -25.98% | -53.57% |
| Spread/Supp. | +6.45% | +25.05% | +7.05% |
| Support | 16,270 | 13,850 | 16,180 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A287840 Stock
- Charts IntoCell, Inc.
Select your edition
All financial news and data tailored to specific country editions
